Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

International Multiple Sclerosis Genetics Consortium, Patsopoulos, Nikolaos A., Baranzini, Sergio E., Santaniello, Adam, Shoostari, Parisa, Cotsapas, Chris, Wong, Garrett, Beecham, Ashley H. +150 more·2019·Science

Cited by (1,491)

Items 601–700 of 1,491

  1. Bidirectional two-sample Mendelian randomization analyses support causal relationships between structural and diffusion imaging-derived phenotypes and the risk of major neurodegenerative diseases
    Zirui Wang, Xuan Yang, Haonan Li, Siqi Wang, Zhixuan Liu, Yaoyi Wang, Xingyu Zhang, Yayuan Chen, Jiayuan Xu, Jiayuan Xu et al. · 2024 · Translational Psychiatry
  2. Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair
    Rina Aharoni, Ron Milo, Ruth Arnon · 2024 · Pharmacological Reviews
  3. Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MS
    Carla Rodriguez-Mogeda, Melissa M. J. van Gool, Richard van der Mast, Rutger Nijland, Zoë Keasberry, Lisanne van de Bovekamp, Myrthe A. M. van Delft, Carmen Picón, Richard Reynolds, Joep Killestein et al. · 2024 · Scientific Reports
  4. A multi-regional human brain atlas of chromatin accessibility and gene expression facilitates promoter-isoform resolution genetic fine-mapping
    Pengfei Dong, Liting Song, Jaroslav M. Bendl, Ruth Misir, Zhiping Shao, Jonathan Edelstien, David A. Davis, Vahram H. Haroutunian, William K. Scott, Susanne Acker et al. · 2024 · Nature Communications
  5. Abnormal body mass index is associated with risk of multiple sclerosis: A systematic review and meta-analysis
    Mohammad Mohammadi, Aynaz Mohammadi, Adrina Habibzadeh, Rojin Korkorian, Mobin Mohamadi, Vahid Shaygannejad, Aram Zabeti, Omid Mirmosayyeb · 2024 · Obesity Research & Clinical Practice
  6. Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation
    Benjamin M. Jacobs, Christiane Gasperi, Sudhakar Reddy Kalluri, Raghda Al-Najjar, Mollie O. McKeon, Jonathan Else, Albert Pukaj, Friederike Held, Stephen J. Sawcer, Maria Ban et al. · 2024 · Cell Reports Medicine
  7. The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections
    Zuber Khan, Sidharth Mehan, Pankaj Kumar Maurya, Aakash Kumar, Ghanshyam Das Gupta, Acharan Singh Narula, Reni E. Kalfin · 2025 · Endocrine Metabolic & Immune Disorders - Drug Targets
  8. Multiple sclerosis and infection: history, EBV, and the search for mechanism
    Elliott Daniel SoRelle, Micah A. Luftig · 2025 · Microbiology and Molecular Biology Reviews
  9. Mitochondria‐Related Genome‐Wide Mendelian Randomization Identifies Putatively Causal Genes for Neurodegenerative Diseases
    Zheyi Wang, Yize Sun, Zetai Bai, Mei Li, Deyuan Kong, Guanzhao Wu · 2025 · Movement Disorders
  10. Genotype and Phenotype in Multiple Sclerosis—Potential for Disease Course Prediction?
    Vilija Jokubaitis, Yuan Zhou, Helmut Butzkueven, Bruce V. Taylor · 2018 · Current Treatment Options in Neurology
  11. No differential gene expression for CD4+ T cells of MS patients and healthy controls
    Ina Skaara Brorson, Anna Eriksson, Ingvild Sørum Leikfoss, Elisabeth Gulowsen Celius, Pål Berg‐Hansen, Lisa F. Barcellos, Tone Berge, Hanne Flinstad Harbo, Steffan D. Bos · 2019 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  12. Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis—A Possible Cause of Constitutive NF-κB Activation
    Jun Yan, Pamela McCombe, Michael P. Pender · 2020 · Journal of Clinical Medicine
  13. Network-Based Target Prioritization and Drug Candidate Identification for Multiple Sclerosis: From Analyzing “Omics Data” to Druggability Simulations
    Yang Ji, Hongchun Li, Fan Wang · 2021 · ACS Chemical Neuroscience
  14. Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis
    Michael Hecker, Brit Fitzner, Elena Putscher, Margit Schwartz, Alexander Winkelmann, Stefanie Meister, Aleš Dudešek, Dirk Koczan, Peter Lorenz, Nina Boxberger et al. · 2022 · EBioMedicine
  15. Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment
    Andi Liu, Astrid Marilyn Manuel, Yulin Dai, Zhongming Zhao · 2022 · BMC Genomics
  16. Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease
    Leire Iparraguirre, Danel Olaverri-Mendizabal, Telmo Blasco et al. · 2020 · Biomedicines
  17. Low sun exposure acts synergistically with high Epstein−Barr nuclear antigen 1 (EBNA‐1) antibody levels in multiple sclerosis etiology
    Anna Karin Hedström, Jesse Huang, Nicole Brenner · 2021 · European Journal of Neurology
  18. Genes associated with grey matter volume reduction in multiple sclerosis
    Jie Sun, Yingying Xie, Qiuhui Wang, Junlin Shen, Wen Qin, Ningnannan Zhang, Chunshui Yu · 2021 · Journal of Neurology
  19. GWAS-associated variants, non-genetic factors, and transient transcriptome in multiple sclerosis etiopathogenesis: A colocalization analysis
    Gianmarco Bellucci, Renato Umeton, Rachele Bigi, Silvia Romano, Maria Chiara Buscarinu, Roberta Reniè, Virginia Rinaldi, Raffaella Pizzolato Umeton, Emanuele Morena, Carmela Romano et al. · 2021 · Journal of the Neurological Sciences
  20. Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis
    Melissa Sorosina, Silvia Peroni, Elisabetta Mascia, Silvia Santoro, Ana Maria Osiceanu, Laura Ferrè, Ferdinando Clarelli, Antonino Giordano, Miryam Cannizzaro, Filippo Martinelli Boneschi et al. · 2022 · Genes
  21. Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis
    Valery Fuh Ngwa, Yuan Zhou, Phillip E. Melton, Ingrid A.F. van der Mei, Jac Charlesworth, Xin Lin, Amin Zarghami, Simon Broadley, Anne‐Louise Ponsonby, Steve Simpson et al. · 2022 · Scientific Reports
  22. Modeling gene interactions in polygenic prediction via geometric deep learning
    Han Li, Jianyang Zeng, Michael P. Snyder, Sai Zhang · 2024 · Genome Research
  23. SingleBrain: A Meta-Analysis of Single-Nucleus eQTLs Linking Genetic Risk to Brain Disorders
    Jang, Beomjin, Kailash, BP, Tokolyi, Alex, Cuddleston, Winston H., Ravi, Ashvin, Jung, Sang-Hyuk, Naito, Tatsuhiko, Kim, Beomsu, Kim, Min Seo, Cho, Minyoung et al. · 2025
  24. Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA ‐ DRB1 *1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset
    Steve Simpson, Ellen Morwitch, Samuel Tanner, Sarah M Thomson, Alex Eisner, Rod A. Lea, Trevor John Kilpatrick, Jeannette Lechner‐Scott, Rodney J. Scott, Alexandre Xavier et al. · 2025 · Annals of Neurology
  25. A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19
    Shun Li, Shuai Yuan, Catherine Mary Schooling, Susanna C. Larsson · 2022 · Scientific Reports
  26. Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
    Joachim Burman, Christina Zjukovskaja, Anders Svenningsson · 2022 · Brain Communications
  27. Prominent epigenetic and transcriptomic changes in CD4+ and CD8+ T cells during and after pregnancy in women with multiple sclerosis and controls
    Alberto Zenere, Sandra Hellberg, Georgia Papapavlou, Maria Svenvik, Johan Mellergård, Charlotte Dahle, Magnus Vrethem, Johanna Raffetseder, Mohsen Khademi, Tomas P Olsson et al. · 2023 · Journal of Neuroinflammation
  28. A Mendelian randomization study on causal effects of 25(OH) vitamin D levels on diabetic nephropathy
    Mingjie He, Ting Yang, Ping Zhou, Peiyan Bu, Xionghui Yang, Yan Zou, Aimin Zhong · 2023 · BMC Nephrology
  29. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS
    Michele D. Binder, Eze C. Nwoke, Ellen Morwitch, Chris Dwyer, Vivien Li, Alexandre Xavier, Rod A. Lea, Jeannette Lechner‐Scott, Bruce V. Taylor, Anne‐Louise Ponsonby et al. · 2023 · Neurology Neuroimmunology & Neuroinflammation
  30. Associations between Serum Mineral Nutrients, Gut Microbiota, and Risk of Neurological, Psychiatric, and Metabolic Diseases: A Comprehensive Mendelian Randomization Study
    Wang Li, Bo‐Min Lv, Yuan Quan, Qiang Zhu, Hongyu Zhang · 2024 · Nutrients
  31. Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis
    Wei Zhen Yeh, Rod A. Lea, Jim M. Stankovich, Sandeep Sampangi, Louise Laverick, Anneke van der Walt, Vilija Jokubaitis, Melissa M. Gresle, Helmut Butzkueven · 2024 · Scientific Reports
  32. An integrated toolkit for human microglia functional genomics
    Imdadul Haq, Jason C. Ngo, Nainika Roy, Renshun Pan, Nadiya Nawsheen, Rebecca Chiu, Ya Zhang, Masashi Fujita, Rajesh Kumar Soni, Xuebing Wu et al. · 2024 · Stem Cell Research & Therapy
  33. From progression to progress: The future of multiple sclerosis
    Jiwon Oh, Paul Steven Giacomini, Voon Wee Yong, Fiona Costello, François Blanchette, Mark Steven Freedman · 2024 · Journal of Central Nervous System Disease
  34. Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
    Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, Elizaveta J. James, Mainthan Palendira, Simon H Hawke, Georges E. Grau · 2024 · Sclerosis
  35. Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms
    Douglas S. Goodin · 2024 · Journal of Neurology Neurosurgery & Psychiatry
  36. Adolescent sleep patterns, genetic predisposition, and risk of multiple sclerosis
    Eva M Johansson, Tomas P Olsson, Pernilla Stridh, Ingrid Skelton Kockum, Lars S. Alfredsson, Anna Karin Hedström · 2024 · SLEEP
  37. Efficacy of ginsenoside Rg1 on rodent models of depression: A systematic review and meta-analysis
    Yating Wang, Xiaole Wang, Lei Lan, Yi Zhang · 2024 · Psychopharmacology
  38. Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study
    Ferdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, Melissa Sorosina, Alen Zollo, Fredrik Piehl, Tomas P Olsson, Pernilla Stridh, Maja Jagodic, Bernhard Hemmer et al. · 2024 · Journal of Neurology
  39. Causal associations and shared genetic etiology of neurodegenerative diseases with epigenetic aging and human longevity
    Yu Lian Guo, Guojuan Ma, Yukai Wang, Tingyan Lin, Yang Hu, Tianyi Zang · 2024 · Aging Cell
  40. Causal association between plasma metabolites and diverse autoimmune diseases: a two-sample bidirectional mendelian randomization study
    Xiwen Yuan, Peiyan Yang, Jiapeng Hu, Di-Xin Cai, Bao‐Shan Hu, Gang Rui, Zhiming Lin · 2024 · Frontiers in Immunology
  41. The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases
    Marek J. Konieczny, Murad Omarov, Lanyue Zhang, Rainer Malik, Tom G. Richardson, Sebastian‐Edgar Baumeister, Jürgen Bernhagen, Martin Dichgans, Marios K. Georgakis · 2025 · Communications Biology
  42. A unified framework for cell-type-specific eQTL prioritization by integrating bulk and scRNA-seq data
    Xinyi Yu, Xianghong Hu, Xiaomeng Wan, Zhiyong Zhang, Xiang Wan, Mingxuan Cai, Tianwei Yu, Jiashun Xiao · 2025 · The American Journal of Human Genetics
  43. Emerging roles of SLAMF7 in immune cells and related diseases
    Zheng Zhang, Ying Zhang, Zeyu Chen, Lin Xia · 2025 · Innate Immunity
  44. Nicotinic acetylcholine receptors α7 and α9 modifies tobacco smoke risk for multiple sclerosis
    Farren B. S. Briggs · 2020 · Multiple Sclerosis Journal
  45. Depression in multiple sclerosis patients associated with risk variant near NEGR1
    Steven W. Brugger, Matthew Gardner, Jeremy T. Beales, Farren B. S. Briggs, Mary Feller Davis · 2020 · Multiple Sclerosis and Related Disorders
  46. Exome sequencing reveals novel rare variants in Iranian familial multiple sclerosis: The importance of POLD2 in the disease pathogenesis
    Zahra Salehi, Mohammad Keramatipour, Saeed Talebi, Seyed Shahriar Arab, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian, Maryam Hosseinali Izad · 2021 · Genomics
  47. Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?
    Alexandrina Sartori, Sofia Fernanda Gonçalves Zorzella-Pezavento, Luiza Ayumi Nishiyama Mimura, MarinaBonifácio Denadai, William Danilo Fernandes de Souza, Thais Fernanda de Campos Fraga‐Silva · 2022 · Neural Regeneration Research
  48. BSDE: barycenter single-cell differential expression for case–control studies
    Mengqi Zhang, F Richard Guo · 2022 · Bioinformatics
  49. Generation and characterisation of four multiple sclerosis iPSC lines from a single family.
    Alastair J. Fortune, B. Taylor, J. Charlesworth, K. Burdon, Nicholas B. Blackburn, J. L. Fletcher, A. Mehta, K. Young · 2022 · Stem Cell Research
  50. Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology
    Kao-Jung Chang, Hsin-Yu Wu, Aliaksandr A. Yarmishyn, Cheng-Yi Li, Yu‐Jer Hsiao, Yi‐Chun Chi, Tzu-Chen Lo, He-Jhen Dai, Yi‐Chiang Yang, Ding-Hao Liu et al. · 2022 · International Journal of Molecular Sciences
  51. Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis
    Tingting Jia, Yanni Ma, Fengqin Qin, Feng Han, Chengcheng Zhang · 2022 · Annals of Clinical and Translational Neurology
  52. From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis
    Zoe Dyer, David C. Tscharke, Ian Sutton, Jennifer C. Massey · 2023 · Clinical & Translational Immunology
  53. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis
    Yaochen Zhang, Keyi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, Heyi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng‐Xiao Zhang · 2023 · Neurology and Therapy
  54. The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
    Olivia Ellen, Sining Ye, Danica Nheu, Mary Dass, Maurice Pagnin, Ezgi Öztürk, Paschalis Theotokis, Nikolaos Grigoriadis, Steven Petratos · 2023 · International Journal of Molecular Sciences
  55. Causal relationship between coffee intake and neurological diseases: a Mendelian randomization study
    Jinjin Zhang, Yuhan Liu, Gang Xu, Xuezhong Cao, Wenmin Wang, D. Zhang, M. Zhu · 2023 · European Journal of Clinical Nutrition
  56. Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase
    Zbyšek Pavelek, Francesco Angelucci, Ondřej Souček, Jan Krejsek, Lukáš Sobíšek, Blanka Klímová, Jana Šarláková, Simona Halúsková, Kamil Kuča, Martin Vališ · 2020 · Journal of Clinical Medicine
  57. Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriers
    Anna Karin Hedström, Cameron Adams, X Shao · 2020 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  58. Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics
    Karol Perlejewski, Iwona Bukowska‐Ośko, Małgorzata Rydzanicz, Tomasz Dzieciątkowski, Beata Zakrzewska‐Pniewska, Aleksandra Podlecka‐Piętowska, Agata Filipiak, Krzysztof Barć, Kamila Caraballo Cortés, Agnieszka Pawełczyk et al. · 2020 · PLoS ONE
  59. KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
    Kelly M Hares, Kevin C. Kemp, Samantha Loveless, Claire M Rice, Neil J. Scolding, Emma Clare Tallantyre, Neil P. Robertson, Alastair Wilkins · 2021 · Journal of Neurology
  60. Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis
    Helene Højsgaard Chow, Jacob Talbot, Lisbet Marstrand, Henrik Lundell, Hartwig Roman Siebner, Helle Bach Søndergaard, Finn Thorup Sellebjerg · 2021 · Multiple Sclerosis and Related Disorders
  61. Multilocus evaluation of genetic predictors of multiple sclerosis
    Yanina Timasheva, Т. Р. Насибуллин, Ilsiyar A. Tuktarova, В. В. Эрдман, Timur R. Galiullin, О. В. Заплахова, К З Бахтиярова · 2021 · Gene
  62. Growth Factors and Their Roles in Multiple Sclerosis Risk
    Hui Lü, Peng-Fei Wu, Denglei Ma, Wan Zhang, Meichen Sun · 2021 · Frontiers in Immunology
  63. Association of germline TYK2 variation with lung cancer and non‐Hodgkin lymphoma risk
    James Yarmolinsky, Christopher Ian Amos, Rayjean J. Hung, Victor Rau Moreno, Kimberley Burrows, Karl Smith‐Byrne, Joshua Ronald Atkins, Paul Brennan, James McKay, Richard Michael Martin et al. · 2022 · International Journal of Cancer
  64. Telomere length and multiple sclerosis: a Mendelian randomization study
    Yazhou Ma, Mengmeng Wang, Xin Chen, Wang Ruan, Jianrong Yao, Xuegan Lian · 2022 · International Journal of Neuroscience
  65. Impact of Multiple Sclerosis Risk Polymorphism rs7665090 on MANBA Activity, Lysosomal Endocytosis, and Lymphocyte Activation
    Adela González‐Jiménez, Pilar López-Cotarelo, Teresa Agudo-Jiménez, Ignacio Casanova, Carlos López de Silanes, Ángeles Martín‐Requero, Fuencisla Matesanz, Elena Urcelay, Laura Espino‐Paisán · 2022 · International Journal of Molecular Sciences
  66. Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
    Oscar‐Danilo Ortega‐Hernandez, Eva María Martínez-Cáceres, Silvia Presas‐Rodríguez, Cristina M. Ramo-Tello · 2023 · International Journal of Molecular Sciences
  67. No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis
    Cinzia Tiloca, Melissa Sorosina, Federica Esposito, Silvia Peroni, Claudia Colombrita, Nicola Ticozzi, Antonia Ratti, Filippo Martinelli Boneschi, Vincenzo Silani · 2018 · Multiple Sclerosis and Related Disorders
  68. The latitude-dependent autoimmune disease risk genes ZMIZ1 and IRF8 regulate mononuclear phagocytic cell differentiation in response to vitamin D
    Grant Peter Parnell, Stephen D. Schibeci, Nicole Fewings, Ali Afrasiabi, Samantha P. L. Law, Shanuka Samaranayake, Jing Hui Kh’ng, Yee Hsu Fong, David Alexander Brown, Christopher Liddle et al. · 2018 · Human Molecular Genetics
  69. The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 status
    Anna Karin Hedström, Ola Hössjer, Jan A. Hillert, Pernilla Stridh, Ingrid Skelton Kockum, Tomas P Olsson, Lars S. Alfredsson · 2019 · Multiple Sclerosis Journal
  70. Predicting self-reported depression after the onset of multiple sclerosis using genetic and non-genetic factors
    Frances M. Wang, Mary Feller Davis, Farren B. S. Briggs · 2020 · Multiple Sclerosis Journal
  71. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes
    Hans Faber, Dunja Kurtoic, Gurumoorthy Krishnamoorthy, Peter C Weber, Benno Pütz, Bertram Müller‐Myhsok, Frank Weber, Till F. M. Andlauer · 2020 · Frontiers in Immunology
  72. Functional characterization of gene regulatory elements and neuropsychiatric disease-associated risk loci in iPSCs and iPSC-derived neurons
    Yang, Xiaoyu, Jones, Ian R., Chen, Poshen B., Yang, Han, Ren, Xingjie, Zheng, Lina, Li, Bin, Li, Yang Eric, Sun, Quan, Wen, Jia et al. · 2023
  73. Identifying independent causal cell types for human diseases and risk variants
    Artem Kim, Zixuan Zhang, Come Legros, Zeyun Lu, Adam J. de Smith, Jill E. Moore, Arun Durvasula, Nicholas Mancuso, Steven Gazal · 2024 · medRxiv
  74. Unlocking Multiple Sclerosis Genetics
    Nitin Sahi, Olga Ciccarelli, Henry Houlden, Declan Chard · 2025 · Neurology
  75. Single-nucleus multiomics reveals the disrupted regulatory programs in three brain regions of sporadic early-onset Alzheimer’s disease
    Andi Liu, Citu Citu, Nitesh Enduru, Xian Chen, Chia-Hao Tung, Tirthankar Sinha, Sofia E. Sepulveda, Astrid Marilyn Manuel, Damian Gorski, Brisa Simões Fernandes et al. · 2025 · Science Advances
  76. Structure–Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 (34) for Autoimmune Disorders
    Yuanjun He, Di Zhu, Kevin L. Greenman et al. · 2023 · Journal of Medicinal Chemistry
  77. Large-scale genome-wide association study to identify causal relationships and potential mediators between education and autoimmune diseases
    Yingjie Li, Jingwei Zhang, Jie Wen, Mingren Liu, Wanyao Liu, Yongzhen Li · 2023 · Frontiers in Immunology
  78. Expression levels of GSDMB and ORMDL3 are associated with relapsing-remitting multiple sclerosis and IKZF3 rs12946510 variant
    Milan Stefanović, Ljiljana Stojković, Ivan Životić, Evica Dinčić, Aleksandra Stanković, Maja Živković · 2024 · Heliyon
  79. The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial
    Wei Zhen Yeh, Melissa M. Gresle, Rod A. Lea, Bruce V. Taylor, Robyn Marjorie Lucas, Anne‐Louise Ponsonby, Deborah F. Mason, Julie Andrew, Hamish G. Campbell, Julia M. Morahan et al. · 2024 · Clinical Immunology
  80. Sex- and species-specific contribution of CD99 to T cell costimulation during multiple sclerosis
    Ingo Winschel, Anne Willing, Jan Broder Engler, Mark Walkenhorst, Nina Meurs, Lars Binkle-Ladisch, Marcel S. Woo, Lena Kristina Pfeffer, Jana K. Sonner, Uwe Borgmeyer et al. · 2024 · Biology of Sex Differences
  81. Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease
    Quentin Le Grand, Ami Tsuchida, Alexandra Koch, Mohammed Aslam Imtiaz, N. Ahmad Aziz, Chloé Vigneron, Laure Zago, Mark G. Lathrop, Alexandre Dubrac, Thierry Couffinhal et al. · 2024 · Molecular Psychiatry
  82. Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis
    Kefu Yu, Ruiqi Jiang, Ziming Li, Xiaohui Ren, Haihui Jiang, Zhigang Zhao · 2024 · Frontiers in Immunology
  83. HLA-transgenic mouse models to study autoimmune central nervous system diseases
    Kyle R. Pressley, Lance Schwegman, Maria Montes de Oca Arena, Carol Chase Huizar, Scott S. Zamvil, Thomas G. Forsthuber · 2024 · Autoimmunity
  84. Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans
    Usman A. Tahir, Jacob L. Barber, Daniel E. Cruz, Meltem Ece Kars, Shuliang Deng, Bjoernar Tuftin, Madeline G Gillman, Mark D. Benson, Jeremy Robbins, Zsu‐Zsu Chen et al. · 2024 · Journal of Clinical Investigation
  85. Ancient viral DNA in the human genome linked to neurodegenerative diseases
    Rodrigo R. R. Duarte, Douglas F. Nixon, Timothy R. Powell · 2024 · Brain Behavior and Immunity
  86. Association between 25(OH) vitamin D and multiple sclerosis: cohort, shared genetics, and Causality
    Xinghao Yu, Hui-Min Lu, Jun Li, Ming-Zhu Su, Xiao-Min Li, Yi Jin · 2024 · Nutrition Journal
  87. Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation
    Volker Siffrin · 2025 · Glia
  88. Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks
    Ching‐Huang Ho, Maxwell A. Dippel, Meghan S. McQuade, LeAnn P. Nguyen, Arpit Mishra, Stephan Pribitzer, Samantha R. Hardy, Harshpreet Chandok, Florence M. Chardon, Troy A. McDiarmid et al. · 2025 · Nature Genetics
  89. Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
    Rosella Mechelli, Renato Umeton, Grazia Manfrè, Silvia Romano, Maria Chiara Buscarinu, Virginia Rinaldi, Gianmarco Bellucci, Riccardo Bigi, Michela Ferraldeschi, Marco Salvetti et al. · 2020 · Genes
  90. PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer’s Disease and Multiple Sclerosis
    Fan Chen, Yan Zhang, Longcai Wang, Tao Wang, Zhifa Han, Haihua Zhang, Shan Gao, Yang Hu, Guiyou Liu · 2021 · Journal of Alzheimer s Disease
  91. Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies
    M. Mortazavi, Öznur Hizarci, L. Gerdes, J. Havla, T. Kümpfel, R. Hohlfeld, S. Stöcklein, D. Keeser, B. Ertl-Wagner · 2021 · NeuroImage: Clinical
  92. Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients
    Pilar López-Cotarelo, Adela González‐Jiménez, Teresa Agudo-Jiménez, Judith Abarca‐Zabalía, Yolanda Aladro, Belén Pilo, Manuel Comabella, Laura Espino‐Paisán, Elena Urcelay · 2021 · Scientific Reports
  93. Life history of a brain autoreactive T cell: From thymus through intestine to blood-brain barrier and brain lesion
    Naoto Kawakami, Hartmut Wekerle · 2024 · Neurotherapeutics
  94. A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
    Elia Gil‐Varea, Marı́a Fedetz, Herena Eixarch et al. · 2020 · Journal of Clinical Medicine
  95. Multiple sclerosis among first‐ and second‐generation immigrant groups in Sweden
    Per Erik Wändell, S. Fredrikson, Axel Carl Carlsson · 2020 · Acta Neurologica Scandinavica
  96. Mining Complex Genetic Patterns Conferring Multiple Sclerosis Risk
    Farren B. S. Briggs, Corriene E. Sept · 2021 · International Journal of Environmental Research and Public Health
  97. Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
    Jennifer Vandooren, Rafaela Vaz Sousa Pereira, Estefanía Ugarte-Berzal et al. · 2021 · Frontiers in Immunology
  98. Identification of novel and rare variants associated with handgrip strength using whole genome sequence data from the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program
    Chloé Sarnowski, Han Chen, Mary Lou Biggs, Sylvia W Wassertheil-Smoller, Jan Bressler, Marguerite R. Irvin, Kathleen A. Ryan, David Karasik, Donna K. Arnett, L. Adrienne Cupples et al. · 2021 · PLoS ONE
  99. Gender-Related Differences in Prodromal Multiple Sclerosis Characteristics: A 7-Year Observation Study
    Jakub Perwieniec, Krzysztof Podwójcic, Michał Maluchnik et al. · 2021 · Journal of Clinical Medicine
  100. Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
    Gianmarco Abbadessa, Giuseppina Miele, Andrea Di Pietro, Maddalena Sparaco, Raffaele Palladino, Ignazio Armetta, Giovanna D’Elia, Francesca Trojsi, Elisabetta Signoriello, Giacomo Lus et al. · 2021 · Neurological Sciences